CTI BioPharma to Present at the JMP Securities Life Sciences Conference on Wednesday, June 16

<br /> CTI BioPharma to Present at the JMP Securities Life Sciences Conference on Wednesday, June 16<br />

PR Newswire


SEATTLE

,

June 9, 2021

/PRNewswire/ — CTI BioPharma Corp. (NASDAQ: CTIC) today announced that management will provide a corporate overview at the JMP Securities Life Sciences Conference at

2:30 p.m. ET

. The conference will be held in a virtual meeting format.

Presentation details:

Event: JMP Securities Life Sciences Conference

Date:

Wednesday, June 16, 2021


Time:

2:30 p.m. ET

The presentation will be webcast live and available for replay from the Investors section of CTI BioPharma’s website at

www.ctibiopharma.com

.


About CTI BioPharma Corp.


We are a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers. We concentrate our efforts on treatments that target blood-related cancers where there is an unmet medical need. In particular, we are focused on evaluating pacritinib, our product candidate currently in active late-stage development, for the treatment of adult patients with myelofibrosis, and in response to the COVID pandemic, severe COVID-19 disease. We are headquartered in

Seattle, Washington

.


CTI BioPharma Investor Contacts:

Argot Partners

+212-600-1902


[email protected]

Cision
View original content to download multimedia:

http://www.prnewswire.com/news-releases/cti-biopharma-to-present-at-the-jmp-securities-life-sciences-conference-on-wednesday-june-16-301308699.html

SOURCE CTI BioPharma Corp.